CN Patent

CN112194623A — 一种乐伐替尼衍生物关键中间体的合成方法

Assigned to Sichuan Inodabo Pharmaceutical Technology Co ltd · Expires 2021-01-08 · 5y expired

What this patent protects

本发明提供了一种乐伐替尼衍生物关键中间体7‑甲氧基‑4‑氧代‑1,4‑二氢喹啉‑6‑甲腈的合成方法，具有合成步骤简单、反应时间短、反应条件温和、易于纯化、收率高且成本低的优点，具有良好的工业化生产前景。

USPTO Abstract

本发明提供了一种乐伐替尼衍生物关键中间体7‑甲氧基‑4‑氧代‑1,4‑二氢喹啉‑6‑甲腈的合成方法，具有合成步骤简单、反应时间短、反应条件温和、易于纯化、收率高且成本低的优点，具有良好的工业化生产前景。

Drugs covered by this patent

Patent Metadata

Patent number
CN112194623A
Jurisdiction
CN
Classification
—
Expires
2021-01-08
Drug substance claim
No
Drug product claim
No
Assignee
Sichuan Inodabo Pharmaceutical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.